201 related articles for article (PubMed ID: 3652931)
1. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
Tapounet R; Marti Ragué I
Drugs Exp Clin Res; 1987; 13(7):447-50. PubMed ID: 3652931
[TBL] [Abstract][Full Text] [Related]
2. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].
Dobiásová M; Frohlich J
Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517
[TBL] [Abstract][Full Text] [Related]
3. Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia.
Shinomiya M; Ishikawa Y; Shirai K; Saito Y; Yoshida S
Arzneimittelforschung; 1987 Sep; 37(9):1069-71. PubMed ID: 3435604
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerance to pirozadil over a long term. Drug surveillance study. The Pirozadil Drug Surveillance Group].
Med Clin (Barc); 1987 Dec; 89(20):858-60. PubMed ID: 3448438
[No Abstract] [Full Text] [Related]
5. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
Bucalossi A; Buzzelli G; D'Alessandro A
Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
[No Abstract] [Full Text] [Related]
7. Effects of ethyl-2-(4-chlorophenyl)-5-ethoxy-4-oxazole acetate (Y-9738) on the serum lipids of patients with hyperlipidemia and/or hypo-HDL-emia.
Kajiyama G; Maruhashi A; Yamada K; Kawamoto T; Nakao S; Kubota S; Tsunoda Y
Arzneimittelforschung; 1984; 34(6):730-3. PubMed ID: 6541494
[TBL] [Abstract][Full Text] [Related]
8. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of lipoprotein changes during gemfibrozil treatment.
Janus ED; Costa D; Ononogbu IC; Lewis B
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
Cenarro A; Artieda M; Gonzalvo C; Meriño-Ibarra E; Arístegui R; Gañán A; Díaz C; Sol JM; Pocoví M; Civeira F;
Am Heart J; 2005 Dec; 150(6):1154-62. PubMed ID: 16338252
[TBL] [Abstract][Full Text] [Related]
11. Achieving vascular risk factor targets: a survey of a London general practice.
Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
[TBL] [Abstract][Full Text] [Related]
12. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
[TBL] [Abstract][Full Text] [Related]
13. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
[TBL] [Abstract][Full Text] [Related]
14. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
Wolffenbuttel BH; Huijberts MS
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of disorders of lipid metabolism with the new lipid regulator X50].
Reuter W; Herrmann W; Sauer I; Janowski K; Dorn H; Steinicke A
Z Gesamte Inn Med; 1986 Mar; 41(5):124-6. PubMed ID: 3754999
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
Wolf HR
Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717
[TBL] [Abstract][Full Text] [Related]
17. Lipid lowering activity of ethanolic extract of leaves of Aegle marmelos (Linn.) in hyperlipidaemic models of Wistar albino rats.
Vijaya C; Ramanathan M; Suresh B
Indian J Exp Biol; 2009 Mar; 47(3):182-5. PubMed ID: 19405383
[TBL] [Abstract][Full Text] [Related]
18. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
19. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
